Nasal Lacrimal Stent Market Size, Share, Outlook, and Opportunity Analysis, 2022-2028
A nasolacrimal stent is a tiny tube
that is used to treat disorders like epiphora as well as congenital
nasolacrimal blockage and dacryocystorhinostomy (DCR). Nasal lacrimal stent
market expansion is anticipated to be fueled by the rising prevalence of
nasolacrimal duct obstruction (NLDO), a frequent condition of the lacrimal
system. For instance, the prevalence of nasolacrimal duct obstruction has been
shown to range from 6% to 20% in neonates worldwide in 2019, according to
statistics released by the NCBI (National Center for Biotechnology
Information).
The nasal
lacrimal stents market is anticipated to grow over the course of the
forecast period as a result of continuous research on treatments for the
disorders of epiphora and dacryocystorhinostomy illness. For instance, Alon
Kahana from the University of Michigan funded a study in October 2019 to assess
the effectiveness and safety of the slit stent II lacrimal stent for the
treatment of nasolacrimal duct obstruction.
Additionally, the availability of
cutting-edge products is anticipated to fuel market expansion. Products like
Nunchaku and BIKA intubation system, a bicanalicular stent used to drain tears
by capillary, are available from the FCI Ophthalmics Company.
Comments
Post a Comment